Development of adjuvanted multi-antigen liver-stage malaria vaccines door Halbroth, B

Identification of immunodominant responses to the Plasmodium falciparum antigens PfUIS3, PfLSA1 and PfLSAP2 in multiple strains of mice door Longley, R, Halbroth, B, Ewer, K, Hill, A, Spencer, A

Development of a molecular adjuvant to enhance antigen-specific CD8+ T cell responses door Halbroth, B, Sebastian, S, Poyntz, H, Bregu, M, Cottingham, M, Hill, A, Spencer, A

Assessment of the Plasmodium falciparum pre-erythrocytic antigen UIS3 as a potential candidate for a malaria vaccine door Longley, R, Halbroth, B, Salman, A, Ewer, K, Hodgson, S, Janse, C, Khan, S, Hill, A, Spencer, A

Pre-clinical development and assessment of viral vectors expressing a fusion antigen of P. falciparum LSA1 and LSAP2 for efficacy against liver-stage malaria door Halbroth, B, Sebastian, S, Salman, A, Ulaszewska, M, Gola, A, Longley, R, Janse, C, Khan, S, Hill, A, Spencer, A

Prime and target immunization protects against liver-stage malaria in mice door Gola, A, Silman, D, Walters, A, Uderhardt, S, Salman, A, Halbroth, B, Bellamy, D, Bowyer, G, Powlson, J, Baker, M, Venkatraman, N, Poulton, I, Berrie, E, Roberts, R, Lawrie, A, Angus, B, Khan, S, Janse, C, Ewer, K, Germain, R, Spencer, A, Hill, A